| Summary: | INTRODUCTION[|]This study, aims to show the intravenous thrombolytic therapy (IV-tPA) given to patients with ischemic stroke within the first 4.5 hours to affect prognosis according to demographic, etiological and clinical factors.[¤]METHODS[|]The study was conducted retrospectively and included 26 acute ischemic stroke patients who only received intravenous thrombolytic therapy in Cankiri State Hospital between January 1, 2019, and January 1, 2020. Demographic information, risk factors, stroke etiologies, symptom to needle time were questioned. First and 24th hours NIHSS scores, pre-stroke, discharge, or first week and thirdmonth mRS scores and complications were evaluated.[¤]RESULTS[|]It was determined that demographic, and etiological factors, ischemic stroke types and the time of IV-tPA administration did not affect prognosis in patients (p>0,05). It was shown that those with mild and moderate baseline and 1st-- hour NIHSS scores had a better prognosis than those with severe scores (p <0.05).[¤]DISCUSSION AND CONCLUSION[|]The study showed that patients with a low NIHSS score at baseline had better 3rd-month mRS. In addition, it has been shown that thrombolytic therapy can be given,and complications can be managed in a secondary care hospital. [¤]
|
|---|
